Company Overview of N M Rothschild & Sons Limited
N M Rothschild & Sons Limited, through its subsidiaries, provides strategic, M&A, wealth management, and fundraising advice and services to governments, companies, and individuals worldwide. The company offers impartial, expert advisory, and execution services; and asset management services, principally in the area of debt fund management for various CLO, leveraged debt, and mezzanine debt vehicles. It also provides private client banking, commercial lending, asset finance, and treasury, including the provision of asset financing to companies and local authorities. The company was founded in 1798 and is based in London, United Kingdom. N M Rothschild & Sons Limited operates as a subsidiary o...
St Swithin's Lane
London, EC4N 8AL
Founded in 1798
Key Executives for N M Rothschild & Sons Limited
Chief Executive Officer and Executive Director
Executive Director and Member of Credit Committee
Executive Director and Member of New Client Acceptance Committee
Compensation as of Fiscal Year 2016.
N M Rothschild & Sons Limited Key Developments
NM Rothschild & Sons Ltd Wins Multiple Awardees Contract for Corporate Finance Services
Jul 2 16
NM Rothschild & Sons Ltd., London, won a multiple awardees contract award from The Minister for the Cabinet Office acting through Crown Commercial Service, part of the Crown to provide corporate finance services.
Catterton Seeks Options For Ferrara Candy
Jul 1 16
L Catterton is seeking strategic options for Ferrara Candy Company, Inc. The options may include an initial public offering or sale of Ferrara Candy Company, Inc. Catterton hired Rothschild and Morgan Stanley (NYSE:MS) to explore options for Ferrara, people with knowledge of the matter said.
China Jianyin In Talks To Acquire SGD
May 10 16
China Jianyin Investment Limited (JIC) has entered into exclusive discussions with Oaktree Capital Management, L.P. to acquire SGD S.A. Jürgen Sackhoff, President of SGD said: "We are keen to welcome JIC as our proposed new shareholder, as they are a long-term investor which fits extremely well with our business model and strategic roadmap. Moreover, the combination with JIC will open us exciting new growth opportunities in Asia. All of this will benefit our employees in France and across the globe, our customers and partners. As a conclusion, I am very excited about the future of SGD Pharma with JIC being the new shareholder. I also thank Oaktree for their support to develop SGD Pharma into a standalone company.” The proposed transaction will be submitted to the relevant workers’ council of SGD. It will be subject to competition and other regulatory approvals. JPMorgan Chase & Co. (NYSE:JPM) and Lazard Ltd. (NYSE:LAZ) acted as financial advisors and Weil, Gotshal & Manges acted as legal advisor to Oaktree. N M Rothschild & Sons Limited acted as financial advisor and Bredin Prat acted as legal advisor to JIC.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|